Mr. Cooper is a pharmaceutical executive with over 25 years of experience in general management, corporate development, product development, and manufacturing. He is currently the Chief Business Officer for NuvOx Pharma and previously served as interim CEO and advisor to Sonoran Biosciences. From 1996 to 2010, Mr. Cooper served as Executive Vice President of Corporate and Product Development at Medicis Pharmaceutical Corporation, where he was responsible for corporate development, clinical and technical operations, business unit management, as well as frequent representation for the company with investors and equity analysts. During his tenure at Medicis, the company’s revenues grew to over $600 million annually. Prior to that, he served in senior roles with Schein Pharmaceutical, Smith and Nephew, and GD Searle. Mr. Cooper is earned his bachelor’s degree in Business Administration, Management and Operations from Northeastern Illinois University and holds an MBA from the Executive Program at Arizona State University.
Current role